Navigation Links
Research may lead to new and improved vaccines
Date:3/14/2011

Alum is an adjuvant (immune booster) used in many common vaccines, and Canadian researchers have now discovered how it works. The research by scientists from the University of Calgary's Faculty of Medicine is published in the March 13 online edition of Nature Medicine. The new findings will help the medical community produce more effective vaccines and may open the doors for creating new vaccines for diseases such as HIV or tuberculosis.

"Understanding alum properties will help other vaccines because we are one step deeper into the mechanistic insight of adjuvants, which are essential for human vaccines to work," says Yan Shi, PhD, from the Faculty of Medicine and a member of the Snyder Institute of Infection, Immunity and Inflammation.

Alum is a common grocery store staple used in pickling. It is very effective in inducing antibody responses and is the only human vaccine adjuvant approved for large-scale immunization. It has been in use for 90 years and appears in almost all vaccines we receive as without an adjuvant vaccines in general do not work.

"Knowledge provided in this study may help us manipulate alum with additional adjuvant components to direct an attack against major diseases which require a killer T cell response such as HIV, Tuberculosis, and malaria," says Tracy Flach from the Faculty of Medicine and the study's first author.

The research reveals that alum interacts with a group of immune cells called dendritic cells via their cell membrane lipids. Dendritic cells, the sentinel of our immune system, heed the call of alum and move on to activate a group of T cells that control antibody production.

The breakthrough came as the team made use of a cutting edge technology developed in the Faculty of Medicine called single cell force spectroscopy. This technique allowed the UCalgary team to study individual cells and measure their responses to alum.


'/>"/>

Contact: Marta Cyperling
mcyperli@ucalgary.ca
403-210-3835
University of Calgary
Source:Eurekalert  

0

GOOD

Page: 1

Related medicine news :

1. UCIs Dr. Bang H. Hoang, colleagues recognized for bone cancer research
2. Mount Sinai researcher finds unexpected temperature sensation for a light detector
3. InDevR awarded $3 million grant from NIH for influenza-related research
4. Research suggests HIV-infected patients at higher risk for bone fractures
5. CWRU researcher sends message to postmenopausal women: Increase yearly dental checkups
6. Sones Innovation Award honors breast cancer vaccine research
7. New lupus drug results from Scripps Research technology
8. Researchers find smoking may increase risk for lung disease
9. Researchers identify new biomarker for Creutzfeldt-Jakob disease, the human form of mad cow disease
10. Deep brain stimulation research expands at Barrow
11. Barrow researcher launches depression study
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Research may lead to new and improved vaccines
(Date:5/18/2013)... Minn. -- Regular consumption of coffee is associated ... (PSC), an autoimmune liver disease, Mayo Clinic research ... Digestive Disease Week 2013 conference in Orlando, Fla. ... the bile ducts that results in inflammation and ... the liver, liver failure and biliary cancer. , ...
(Date:5/18/2013)... May 18, 2013 Today, Zane ... insurance agents’ role in Marketplaces . Zane Benefits, ... employer sponsored health benefits, is the leader in ... health reimbursement arrangements . , According to ... Human Services (HHS) recently released a much-anticipated statement ...
(Date:5/18/2013)... 2013 The “World Healthcare IT Market: ... the major market drivers, restraints, and opportunities in North ... Browse , 89 market data ... on "Healthcare IT Market" , http://www.marketsandmarkets.com/Market-Reports/healthcare-information-technology-market-136.html ... reports. , The global healthcare IT market is expected ...
(Date:5/18/2013)... 2013 As metal-on-metal hip implant ... country, Bernstein Liebhard LLP notes that a new study ... tissue damage before they experience any pain from a ... Daily will appear in the Journal of Bone & ... screens of their hips. The researchers found tissue ...
(Date:5/18/2013)... The “Sleep Apnea Diagnostic & Therapeutic Devices Market [Polysomnographs, ... Oral Appliances, Nasal EPAP, Neurostimulation] Global End-user Analysis, Competitive ... major market drivers, restraints, and opportunities in North America, ... , 147 market data tables ... 318 pagesand in-depth TOC of “Sleep Apnea ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 2Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 3Health News:Zane Benefits Publishes New Information on Insurance Agents’ Role in Marketplaces 4Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 2Health News:Healthcare IT Market to reach US$ 162.2 Billion by 2015 at a CAGR of 10.2% - New Report by MarketandMarkets 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 2Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 3Health News:Metal-on-Metal Hip Implants: Bernstein Liebhard LLP Comments on New Study Finding that Tissue Damage Precedes Pain in Metal-on-Metal Hip Replacement Patients 4Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 2Health News:Sleep Apnea Devices Market to reach $19.72 Billion by 2017 - New Report by MarketandMarkets 3
... at the Queensland Institute of Medical Research (QIMR) and the ... and successfully treated it by performing an experimental stem cell ... and out of hospital Katie Pulling had almost given up ... hearing the doctors say, ,We don,t know what is wrong, ...
... the forefront of HIV prevention research will be taking center ... L. Lawrence Convention Center in Pittsburgh May 22-25. M2010 ... community advocates and experts in global health who are working ... of the world. Nearly 1,000 participants from 47 countries will ...
... ... to look for. Flexible Assembly Systems uncovers the great torque screwdriver mystery with its very ... ... you don’t know what to look for. A torque screwdriver comes in many different ...
... controlled severe disease using less medication , MONDAY, May ... be a mouse click away, Dutch researchers report. , ... program maintained long-term control of severe asthma but needed ... do so, the study found. , "We know that ...
... researchers say , MONDAY, May 17 (HealthDay News) -- ... organophosphate pesticides, commonly found on berries, celery and other ... (ADHD) in children. , At this point, though, there ... ADHD, stated the authors of a paper appearing in ...
... Fighting ... takes is one look at the brand and the name to get an instant smile and chuckle. ... , ... Drink (FCE) is a concept that was born on the cusp of the energy drink boom that ...
Cached Medicine News:Health News:Australian researchers identify a new disease 2Health News:Press briefings at International Microbicides Conference May 22-25 2Health News:Press briefings at International Microbicides Conference May 22-25 3Health News:Press briefings at International Microbicides Conference May 22-25 4Health News:Press briefings at International Microbicides Conference May 22-25 5Health News:Flexible Assembly Systems Announces Torque Screwdriver Application Guide 2Health News:Web-Based Program Can Boost Asthma Care 2Health News:Pesticides on Produce Tied to ADHD in Children 2Health News:Pesticides on Produce Tied to ADHD in Children 3Health News:Unique Marketing Approach to the Energy Drink Market Brings Explosive Response 2
(Date:5/16/2013)... , May 16, 2013  HeartWare International, Inc. (NASDAQ: ... of less invasive, miniaturized circulatory support technologies that are revolutionizing ... Doug Godshall is scheduled to present ... EDT on Monday, May 20, 2013.  The conference is being ... A live webcast of the Company,s presentation at ...
(Date:5/16/2013)... , May 16, 2013  Amgen (NASDAQ: AMGN ... on Tuesday, May 21, 2013, at the Sheraton New York ... beginning at 10:00 a.m. Eastern Daylight Time. Joseph ... Research and Development at Amgen, will present at the conference. ... Events Calendar on Amgen,s website, www.amgen.com , under Investors. ...
(Date:5/16/2013)... -- OrthoView PSL will allow individual surgeons ... widely-used OrthoView digital templating software via the Cloud and ... started. OrthoView, the leading independent provider of ... dedicated to enabling orthopaedic surgeons in hospitals and private ... film is unavailable. Over 5,000 orthopaedic surgeons in the ...
Breaking Medicine Technology:HeartWare Presentation At The 2013 UBS Global Healthcare Conference To Be Webcast 2OrthoView Announces the U.S. Launch of a New, Subscription-based, Digital Planning and Templating Solution for Individual Orthopaedic Surgeons 2
... Medical, Inc. (OTCBB: AEMD), the pioneer in developing ... cancer, announced today the introduction of HER2osome™, a ... of HER2+ breast cancer, which is characterized by ... over-expression of HER2 protein.  Breast cancer represents the ...
... Sept. 21, 2011 Reportlinker.com announces that a ... catalogue: Generic Drugs: The ... http://www.reportlinker.com/p0619264/Generic-Drugs-The-Global-Market-Focus-on-the-Americas.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Machine_Tool_and_Equipment ... examination of the strategies employed by companies specializing ...
Cached Medicine Technology:Aethlon Medical Introduces HER2osome™, A Novel Therapeutic Device Strategy to Address Breast Cancer 2Aethlon Medical Introduces HER2osome™, A Novel Therapeutic Device Strategy to Address Breast Cancer 3Aethlon Medical Introduces HER2osome™, A Novel Therapeutic Device Strategy to Address Breast Cancer 4Aethlon Medical Introduces HER2osome™, A Novel Therapeutic Device Strategy to Address Breast Cancer 5Generic Drugs: The Global Market: Focus on the Americas 2Generic Drugs: The Global Market: Focus on the Americas 3Generic Drugs: The Global Market: Focus on the Americas 4Generic Drugs: The Global Market: Focus on the Americas 5Generic Drugs: The Global Market: Focus on the Americas 6Generic Drugs: The Global Market: Focus on the Americas 7Generic Drugs: The Global Market: Focus on the Americas 8Generic Drugs: The Global Market: Focus on the Americas 9Generic Drugs: The Global Market: Focus on the Americas 10
... Our Buffered Wright-Giemsa Stain is ... contains the fixative, buffer, and ... staining of blood smears. It ... bottle for ease of use ...
This Wright-Giemsa is a dual-use stain for peripheral blood and bone marrow smears. It produces somewhat darker results when compared with Giemsa, particularly in the blue to magenta shades....
Our Wright stain is a dual-use stain for peripheral blood and bone marrow smears. It produces results similar to those of the Giemsa stain with a slightly greater contrast....
Albumin (BCP). Storage temp: 15 - 30 C. Linearity: 0.5 - 8.0 g/dl. Expected values: 3.5 - 5.5 g/dl. Available with calibrator. Performs 250 number of tests....
Medicine Products: